4//SEC Filing
Quigley Jill M. 4
Accession 0001799780-25-000004
CIK 0001831363other
Filed
Nov 4, 7:00 PM ET
Accepted
Nov 5, 6:17 PM ET
Size
9.1 KB
Accession
0001799780-25-000004
Insider Transaction Report
Form 4
Quigley Jill M.
Director
Transactions
- Exercise/Conversion
Common Stock
2025-11-04$9.24/sh+24,520$226,565→ 24,520 total - Sale
Common Stock
2025-11-04$18.00/sh−24,520$441,360→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-11-04−24,520→ 3,955 totalExercise: $9.24Exp: 2030-12-29→ Common Stock (24,520 underlying)
Footnotes (2)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 18, 2024.
- [F2]1/3rd of the shares subject to the option vested on the first anniversary measured from December 29, 2020 (the "Vesting Commencement Date"), and 1/36th of the total number of shares vested monthly thereafter, such that 100% of the shares subject to the option were fully vested and exercisable on the third anniversary of the Vesting Commencement Date.
Documents
Issuer
Terns Pharmaceuticals, Inc.
CIK 0001831363
Entity typeother
Related Parties
1- filerCIK 0001799780
Filing Metadata
- Form type
- 4
- Filed
- Nov 4, 7:00 PM ET
- Accepted
- Nov 5, 6:17 PM ET
- Size
- 9.1 KB